NASDAQ · BDSX
Biodesix, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BDSX: Nov 05, 2026
Biodesix, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.74. The reported EPS for the same quarter last year was $-1.16.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.74 | $-0.72 | $-0.75 | 3 |
| Dec 2026 | $-0.44 | $-0.39 | $-0.47 | 3 |
| Mar 2027 | $-0.60 | $-0.53 | $-0.65 | 3 |
| Jun 2027 | $-0.47 | $-0.42 | $-0.55 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · BNK Invest- Zacks · Oct 29, 11:00 AM EDTAll You Need to Know About Biodesix (BDSX) Rating Upgrade to BuyBiodesix (BDSX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Oct 29, 9:00 AM EDTWill Biodesix, Inc. (BDSX) Report Negative Earnings Next Week? What You Should KnowBiodesix (BDSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 28, 7:35 AM EDTLabcorp Holdings (LH) Q3 Earnings and Revenues Surpass EstimatesLabcorp (LH) delivered earnings and revenue surprises of +2.80% and +1.13%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 5, 7:09 AM EDTBeat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in FocusTMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.
- Fintel · Oct 2, 10:00 AM EDTBiodesix Consensus Price Target Raised by 12.20% to $37.54The average one-year price target for Biodesix (NASDAQGM:BDSX) has been revised to $37.54 / share. This is an increase of 12.20% from the prior estimate of $33.46 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitute
- Zacks · Sep 28, 10:03 AM EDTBiodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive TestsBDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.
- RTTNews · Sep 27, 8:23 AM EDTBiodesix Reveals Two Developing MRD Solution Collaborations With Bio-Rad And Thermo Fisher(RTTNews) – Biodesix Inc. (BDSX), a diagnostic solutions company, last week reported strategic progress for two programmes regarding Molecular Residual Disease (MRD) solutions for cancer diagnosis. Biodesix is developing the tests for tumor-informed and tumor-naive MRD using it
- Zacks · Aug 31, 12:00 PM EDTWhat Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?Does Biodesix, Inc. (BDSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Aug 31, 9:55 AM EDTWall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?The consensus price target hints at a 26.7% upside potential for Biodesix (BDSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- RTTNews · Aug 26, 4:33 AM EDTBiotech Stocks At 52-Week Highs – GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%(RTTNews) – The following biotech stocks reached a 52-week high on August 25, 2026, driven by key catalysts including positive clinical trial results or the issuance of quarterly reports.
- Zacks · Aug 24, 12:37 PM EDTPRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.
- BNK Invest · Aug 13, 10:35 AM EDTThursday 8/13 Insider Buying Report: PRMB, BDSXAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. At Primo Brands, a filing with the SEC revealed that on Monday, CEO Eric J. Foss pu
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Biodesix, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.